These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28125239)
41. Materials engineering of solid-state dosage forms. Li T Pharm Res; 2008 Apr; 25(4):949-51; discussion 951-2. PubMed ID: 17985215 [No Abstract] [Full Text] [Related]
42. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs. Baghel S; Cathcart H; O'Reilly NJ J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314 [TBL] [Abstract][Full Text] [Related]
43. Theme issue "Solid state and solid dosage forms". Kleinebudde P Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869 [No Abstract] [Full Text] [Related]
44. A new design for the review and appraisal of semi-solid dosage forms: Semi-solid Control Diagram (SSCD). Nardi-Ricart A; Linares MJ; Villca-Pozo F; Pérez-Lozano P; Suñé-Negre JM; Bachs-deMiquel L; Roig-Carreras M; Suñé-Pou M; Nofrerias-Roig I; García-Montoya E PLoS One; 2018; 13(9):e0201643. PubMed ID: 30192759 [TBL] [Abstract][Full Text] [Related]
45. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134 [TBL] [Abstract][Full Text] [Related]
46. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances. Reutzel-Edens SM Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688 [TBL] [Abstract][Full Text] [Related]
47. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation. Patil H; Tiwari RV; Repka MA AAPS PharmSciTech; 2016 Feb; 17(1):20-42. PubMed ID: 26159653 [TBL] [Abstract][Full Text] [Related]
48. Applications of process analytical technology to crystallization processes. Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586 [TBL] [Abstract][Full Text] [Related]
49. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance. Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651 [TBL] [Abstract][Full Text] [Related]